Pharmacogenomic diversity of clinically significant cancer treatment biomarkers in ancestrally diverse US population.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Enhancing Large-Scale Pharmacogenetic Studies in African Populations for Clinical Care and Drug Development2025 · 6 citations
2. 2Genetic ancestry-associated differences in genomic profiling and treatment patterns in pancreatic ductal adenocarcinoma (PDAC).2024
3. 3Abstract 23: Pharmacogenomics of Breast, Cervical and Prostate Cancers: Cytochrome P450 Variants and Implications for Chemotherapy in African Populations2025
4. 4The clinical and molecular landscape of breast cancer in women of African and South Asian ancestry2024 · 3 citations
5. 5Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population2024 · 1 citations